Safety and Comparative Open Clinical Study on “Ayavaththi Chooranam” And “Chiteramoola Ennai” Two Siddha Drugs in the Treatment of Lumbar Spondylosis.
Journal Title: International Journal of Medical Science And Advanced Clinical Research (IJMACR) - Year 2019, Vol 2, Issue 3
Abstract
Background: Siddha system of medicine is most ancient and spiritually enriched one. The drugs ‘Ayavaththi Chooranam’ as internal drug (Anupoga vaithya Navaneetham) and “Chiteramoola Ennai” (Sarabendirar Vaithya Muraigal - Vaatharoga chikichai ) for external application to evaluate their efficacy in treating “Thandaga Vatham” (Lumbar Spondylosis). In recent research, it has been found that, kadukkai - Terminalia chebula, chukku – Zingiber officinale, Nilavagai – Cassia senna, were the drug of ‘Ayavaththi chooranam’ has, anti arthritic, anti - inflammatory properties. Materials And Methods: The Study on Thandagavatham was carried out in the Department of Sirappu Maruthuvam, National Institute of Siddha over 12 months among 40 patients. On the first day of the treatment, Purgation will be given in the early morning with Agastiyar kulambu – 130 m.g o.d with ginger juice in empty stomach.Next day onwards the trial drug Ayavaththi chooranam, internally for 48 days and Chitermoola Ennai externally are given continuously for 48 days. OP patients are requested to visit the hospital once in 7days (FormIV). In each and every visit clinical assessment is done and prognosis is noted in the Prescribed Proforma. Under supervision of faulty members for IP Patients clinical assessment is done daily. 20 patients will be given Varmam treatment along with trial medicines and the remaining 20 will be given medicine only. If there is need of IP patients will be admitted in the ward for the clinical assessment. Laboratory investigations and Radiological investigations are done on the First day and the last day of the trial. At the end of the treatment, the patients were advised to visit the OPD for follow-up. Results: Among the 40 cases, after the treatment the pain was reduced in 18 cases (45%), mild pain was present in 8 cases (20%), moderate pain was present in 9 cases (22.5%), severe pain was present in 5 cases (12.5%). Conclusion: The clinical trial proves the efficacy of he trail drugs by reducing the clinical signs and symptoms like radiating pain, numbness, restricted movements and provides better improvement.
Authors and Affiliations
A. Jenifer Lancy
Keywords
Related Articles
- EP ID EP589783
- DOI -
- Views 102
- Downloads 0
Study on Laparoscopic Cholecystectomy for Acute Cholecystitis in Bhagalpur
Acute cholecystitis with or without stone is a common cause of acute abdominal pain. Laparoscopic cholecystectomy has been accepted as the gold standard procedure for management of symptomatic gallstone and chronic chole...
Study on Treatment of Sacrococcygeal Pilonidal Sinus By Limbergflap Versus Primary Closure At Bhagalpur
Sacrococcygeal Pilonidal Sinus isan acquired chronic intermittent disease, usually seen in young adult especially males. This study was undertaken to compare the result of rhomboid excision followed by Limberg flap with...
Lipoma of the Lower Lip- A Case Report
Lipomas are rare intraoral tumors. The usual lesions consist of a well circumscribed, lobulated mass of mature fat cells. We present a rare case of lipoma affecting the lower lip of a 55-year old male patient. The surgic...
Prognostic Profile of Scrub Typhus in Association with Co Existing Clinical Infection in Hadoti Region of Rajasthan
Scrub typhus is a disease caused due to infection with Orientia tsutsugamushi, and is spread by leptotrombidiummites (chiggers). In tropical areas, concurrent infectionof malaria and dengue can occur as bo...
A Review article on: Clinical Application of Shat Kriya Kala.
Prevention is better than cure has always been a golden standard and underlined principle for health. Proper quality ,quantity and timely “balanced diet ’’ , is very essential for a h...